Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 12/20 | 0.42 |
| ▸ | AGTR2 | P50052 | 12/20 | 0.42 |
| ▸ | BRS3 | P32247 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9736608 | 1.00 | AGTR1 (0.42) | AGTR1AGTR2BRS3FOLH1LTB4R | |
| SCHEMBL6005416 | 0.90 | AGTR1 (0.53) | AGTR1AGTR2BRS3 | |
| SCHEMBL6005421 | 0.90 | AGTR1 (0.53) | AGTR1AGTR2BRS3 | |
| SCHEMBL9532017 | 0.82 | AGTR1 (0.55) | AGTR1AGTR2BRS3FOLH1LTB4R | |
| SCHEMBL6006743 | 0.81 | AGTR1 (0.55) | AGTR1AGTR2 | |
| SCHEMBL6006747 | 0.81 | AGTR1 (0.55) | AGTR1AGTR2 | |
| SCHEMBL6004824 | 0.81 | AGTR1 (0.58) | AGTR1AGTR2 | |
| SCHEMBL6004823 | 0.81 | AGTR1 (0.58) | AGTR1AGTR2 | |
| SCHEMBL9528852 | 0.80 | FOLH1 (0.41) | AGTR1AGTR2FOLH1LTB4RLTB4R2 | |
| SCHEMBL9739525 | 0.80 | AGTR1 (0.54) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992004335-A2 | RENAL-SELECTIVE BIPHENYLALKYL 1H-SUBSTITUTED-1,2,4-TRIAZOLE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION | G.D. SEARLE & CO. (US) | 1992-03-19 | — | — | WO | disclosed |